PRINCIPAL FINANCIAL GROUP INC – Vertex Pharmaceuticals Incorporated Transaction History
PRINCIPAL FINANCIAL GROUP INC portfolio value:
$103.12M
portfolio value
PRINCIPAL FINANCIAL GROUP INC quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +12.56% | 39.73K shares | 13.95M | $289.54 | 356.15K |
| Q2 2022 | share | Increase | +5.18% | 15.59K shares | 10.65M | $281.79 | 316.42K |
| Q1 2022 | share | Decrease | -1.79% | -5.47K shares | 11.24M | $260.97 | 300.83K |
| Q4 2021 | share | Decrease | -4.29% | -13.73K shares | 9.21M | $222.45 | 306.31K |
| Q3 2021 | share | Increase | +1.48% | 4.65K shares | -5.53M | $181.39 | 320.04K |
| Q2 2021 | share | Decrease | -3.55% | -11.61K shares | -6.67M | $201.63 | 315.38K |
| Q1 2021 | share | Decrease | -6.20% | -21.63K shares | -12.12M | $214.89 | 326.99K |
| Q4 2020 | share | Decrease | -5.10% | -18.73K shares | -17.57M | $236.34 | 348.62K |
| Q3 2020 | share | Decrease | -6.21% | -24.32K shares | -13.74M | $272.12 | 367.36K |
| Q2 2020 | share | Increase | +6.25% | 23.03K shares | 25.99M | $290.31 | 391.68K |
| Q1 2020 | share | Increase | +0.18% | 671 shares | 7.15M | $237.95 | 368.64K |
| Q4 2019 | share | Decrease | -2.46% | -9.26K shares | 16.65M | $218.95 | 367.97K |
| Q3 2019 | share | Decrease | -0.53% | -1.99K shares | -5.63M | $169.42 | 377.23K |
| Q2 2019 | share | Increase | +0.43% | 1.62K shares | 84K | $183.38 | 379.23K |
| Q1 2019 | share | Decrease | -0.34% | -1.28K shares | 6.67M | $183.95 | 377.61K |
| Q4 2018 | share | Decrease | -1.44% | -5.53K shares | -11.30M | $165.71 | 378.89K |
| Q3 2018 | share | Increase | +2.11% | 7.95K shares | 10.10M | $192.74 | 384.42K |
| Q2 2018 | share | Decrease | -0.12% | -461 shares | 2.55M | $169.96 | 376.47K |
| Q1 2018 | share | Decrease | -0.09% | -322 shares | 4.89M | $162.98 | 376.93K |
| Q4 2017 | share | Increase | +1.47% | 5.45K shares | 7K | $149.86 | 377.25K |
| Q3 2017 | share | Decrease | -2.12% | -8.03K shares | 7.57M | $152.04 | 371.80K |
| Q2 2017 | share | Increase | +2.83% | 10.47K shares | 8.55M | $128.87 | 379.83K |
| Q1 2017 | share | Increase | +1.63% | 5.90K shares | 13.61M | $109.35 | 369.36K |
| Q4 2016 | share | Decrease | -0.35% | -1.27K shares | -5.03M | $73.67 | 363.46K |
| Q3 2016 | share | Increase | +2.85% | 10.09K shares | 1.30M | $87.21 | 364.73K |
| Q2 2016 | share | Increase | +2.61% | 9.01K shares | 3.03M | $86.02 | 354.64K |
| Q1 2016 | share | Increase | +2.49% | 8.41K shares | -14.95M | $79.49 | 345.62K |